MSET — Mindset pharma Cashflow Statement
0.000.00%
HealthcareSpeculativeMicro Cap
- CA$74.96m
- CA$67.85m
- CA$3.91m
Annual cashflow statement for Mindset pharma, fiscal year end - June 30th, CAD millions except per share, conversion factor applied.
2020 June 30th | 2021 June 30th | 2022 June 30th | |
---|---|---|---|
Period Length: | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS |
Status: | Final | Final | Final |
Net Income/Starting Line | -0.482 | -11.7 | -16.6 |
Depreciation | |||
Non-Cash Items | 0.2 | 5.21 | 6.82 |
Unusual Items | |||
Other Non-Cash Items | |||
Changes in Working Capital | 0.072 | -1.94 | 10.1 |
Change in Accounts Receivable | |||
Change in Payable / Accrued Expenses | |||
Net Change in Other Assets & Liabilities | |||
Cash from Operating Activities | -0.21 | -8.37 | 0.386 |
Other Investing Cash Flow Items | 0 | 1.04 | 0 |
Sale of Business | |||
Cash from Investing Activities | 0 | 1.04 | 0 |
Net Issuance / Retirement of Stock | |||
Net Issuance / Retirement of Debt | |||
Cash from Financing Activities | 0.751 | 13.4 | 1.75 |
Beginning Cash Balance | |||
Ending Cash Balance | |||
Net Change in Cash | 0.541 | 6.04 | 2.13 |